Further immunohistochemical analysis of Mapk14 expression at different clinical stages and M stages showed that Mapk14 was significantly highly expressed in tumor tissues, which further suggests the potential use of Mapk14 as a marker of CRC progression. Here, MAPK14 is linked to colorectal carcinoma.